Kate Dellorusso
Stock Analyst at LifeSci Capital
(0.93)
# 3,646
Out of 4,339 analysts
17
Total ratings
42.9%
Success rate
-5.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kate Dellorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UPB Upstream Bio | Maintained: Buy | $42 | $8.21 | +411.57% | 11 | May 19, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Hold | n/a | $0.3337 | - | 2 | May 12, 2026 | |
| CRNX Crinetics Pharmaceuticals | Rated: Buy | $90 → $89 | $36.78 | +141.98% | 4 | May 9, 2026 |
Upstream Bio
May 19, 2026
Maintained: Buy
Price Target: $42
Current: $8.21
Upside: +411.57%
Mereo BioPharma Group
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.3337
Upside: -
Crinetics Pharmaceuticals
May 9, 2026
Rated: Buy
Price Target: $90 → $89
Current: $36.78
Upside: +141.98%